From pharmaceuticals to telecoms, software and even copyright licensing, antitrust authorities are clamping down on abuses of IP rights. James Nurton, Eileen McDermott and Peter Ollier examine why IP is under scrutiny and discuss some pending cases and investigations
Top copyright firms ranked in 19 jurisdictions. Plus: Eileen McDermott explores some areas in which the internet has highlighted a need for change in copyright law
Fasten your seatbelts. John M Carson, Alan Kessler and Hugh Dunlop explain how the PPH works in practice, and ask which applicants will most benefit from it
Businesses should not abandon IP securitisation because of the credit crisis. Instead, argues Stanley Lai, this financing method could make a comeback in Asia
IP assets are often overlooked in insolvency situations. But Eifion Morris and Lucy Harrold say insolvency practitioners, lenders and business partners should all pay more attention
Patent protection and enforcement can be a complex undertaking in Latin America. Corporate and private practice professionals, and a WIPO representative, discuss strategies
Is IP given its due importance in your company? If not, say Andrew Watson and Jordan Hatcher, maybe it's time to stop being a blue personality, and become red or yellow
Barry J Herman and Eric W Schweibenz advise non-US companies on how they can meet the domestic industry requirement at the US ITC
Letter to the editor, from Steven Bennett and David Kappos, IBM
My company is about to launch an advertising campaign, and we think it could become very popular. Should we welcome this and are there are any particular trade mark/branding concerns we should be aware of?
A monthly column devoted to IP curiosities and controversies, named in honour of John of Utynam - who received the world’s first recorded patent in 1449
Federal Circuit’s Brunetti ruling: barring immoral or scandalous marks is unconstitutional restriction of free spee… https://t.co/MivCKFINHg
Federal Circuit rules in Amgen v Sandoz on remand from SCOTUS https://t.co/uYIkfVhCHG https://t.co/2OZAscsz32
RT @mdloney: Canada moves closer to joining the Hague Agreement with the release of proposed new Industrial Design Regulations https://t.co…
End of Year 2017
Tribal sovereign immunity: Taking a wrecking ball to the IPR system
The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2017 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International